BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27649153)

  • 1. Astroglial Activation by an Enriched Environment after Transplantation of Mesenchymal Stem Cells Enhances Angiogenesis after Hypoxic-Ischemic Brain Injury.
    Cho SR; Suh H; Yu JH; Kim HH; Seo JH; Seo CH
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental enrichment synergistically improves functional recovery by transplanted adipose stem cells in chronic hypoxic-ischemic brain injury.
    Seo JH; Kim H; Park ES; Lee JE; Kim DW; Kim HO; Im SH; Yu JH; Kim JY; Lee MY; Kim CH; Cho SR
    Cell Transplant; 2013; 22(9):1553-68. PubMed ID: 23394350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor-2 induced by enriched environment enhances angiogenesis and motor function in chronic hypoxic-ischemic brain injury.
    Seo JH; Yu JH; Suh H; Kim MS; Cho SR
    PLoS One; 2013; 8(9):e74405. PubMed ID: 24098645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells-derived IL-6 activates AMPK/mTOR signaling to inhibit the proliferation of reactive astrocytes induced by hypoxic-ischemic brain damage.
    He M; Shi X; Yang M; Yang T; Li T; Chen J
    Exp Neurol; 2019 Jan; 311():15-32. PubMed ID: 30213506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury.
    Herz J; Köster C; Reinboth BS; Dzietko M; Hansen W; Sabir H; van Velthoven C; Bendix I; Felderhoff-Müser U
    Brain Behav Immun; 2018 May; 70():118-130. PubMed ID: 29454023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury.
    Donega V; Nijboer CH; van Tilborg G; Dijkhuizen RM; Kavelaars A; Heijnen CJ
    Exp Neurol; 2014 Nov; 261():53-64. PubMed ID: 24945601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.
    Ophelders DR; Wolfs TG; Jellema RK; Zwanenburg A; Andriessen P; Delhaas T; Ludwig AK; Radtke S; Peters V; Janssen L; Giebel B; Kramer BW
    Stem Cells Transl Med; 2016 Jun; 5(6):754-63. PubMed ID: 27160705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte.
    Gu Y; He M; Zhou X; Liu J; Hou N; Bin T; Zhang Y; Li T; Chen J
    Sci Rep; 2016 Jan; 6():18587. PubMed ID: 26766745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein profiling and angiogenic effect of hypoxia-cultured human umbilical cord blood-derived mesenchymal stem cells in hindlimb ischemia.
    Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kang D; Chang JW; Choi SW; Kang KS; Kim DI
    Tissue Cell; 2017 Dec; 49(6):680-690. PubMed ID: 28958480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain.
    Park HW; Moon HE; Kim HS; Paek SL; Kim Y; Chang JW; Yang YS; Kim K; Oh W; Hwang JH; Kim JW; Kim DG; Paek SH
    J Neurosci Res; 2015 Dec; 93(12):1814-25. PubMed ID: 26332684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.
    Ishii M; Shibata R; Numaguchi Y; Kito T; Suzuki H; Shimizu K; Ito A; Honda H; Murohara T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2210-5. PubMed ID: 21757660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium.
    Suresh SC; Selvaraju V; Thirunavukkarasu M; Goldman JW; Husain A; Alexander Palesty J; Sanchez JA; McFadden DW; Maulik N
    Int J Cardiol; 2015 Dec; 201():517-28. PubMed ID: 26322599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction.
    Liu C; Fan Y; Zhou L; Zhu HY; Song YC; Hu L; Wang Y; Li QP
    Int J Cardiol; 2015 Jun; 188():22-32. PubMed ID: 25880576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
    Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
    J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis.
    Hu X; Yu SP; Fraser JL; Lu Z; Ogle ME; Wang JA; Wei L
    J Thorac Cardiovasc Surg; 2008 Apr; 135(4):799-808. PubMed ID: 18374759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells stabilize the blood-brain barrier through regulation of astrocytes.
    Park HJ; Shin JY; Kim HN; Oh SH; Song SK; Lee PH
    Stem Cell Res Ther; 2015 Sep; 6():187. PubMed ID: 26420371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin enhances therapeutic potency of mesenchymal stem cells after experimental stroke in rats.
    Hanabusa K; Nagaya N; Iwase T; Itoh T; Murakami S; Shimizu Y; Taki W; Miyatake K; Kangawa K
    Stroke; 2005 Apr; 36(4):853-8. PubMed ID: 15746464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.